Second Significant Sentence Handed Down in "Operation Director's Cut"
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Second Significant Sentence Handed Down in "Operation Director's Cut"

Second Significant Sentence Handed Down in "Operation Director's Cut"

January 08, 2007
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Public Information Office
Phone Number: (571) 362-1934

JAN 8 -- (Alexandria, VA) - Alexandre de Basseville, 36, of Los Angeles, California, and Geneva, Switzerland, was sentenced today to 240 months in prison and ordered to forfeit $528,500, after he pleaded guilty to conspiracy to commit money laundering and conspiracy to distribute MDMA (“Ecstasy”). Chuck Rosenberg, United States Attorney for the Eastern District of Virginia, made the announcement after sentencing by United States District Judge Gerald Bruce Lee.

De Basseville and his co-defendant, Bruno Cavelier d’Esclavelles, 45, of Los Angeles, were arrested as part of the Drug Enforcement Administration’s “Operation Director’s Cut” after a two-year undercover investigation into international money laundering. d’Esclavelles was sentenced to 180 months in prison and ordered to forfeit $125,000 on December 15, 2006. According to court documents, between July 2004 and June 2006, de Basseville and d’Esclavelles met repeatedly with undercover agents posing as international drug traffickers in various locations including: Arlington, Virginia; Los Angeles, California; Miami, Florida; Amsterdam; the Netherlands; and, Geneva, Switzerland. During these meetings, de Basseville and d’Esclavelles negotiated to launder more than $20,000,000 in drug proceeds and to import and distribute more than 500,000 Ecstasy pills. On two occasions, de Basseville and d’Esclavelles took cash, totaling $300,000, which they believed to be proceeds of drug trafficking and laundered it using their Los Angeles business, Limelight Films, Inc. In February 2006, de Basseville and d’Esclavelles arranged the shipment of a package containing 10,000 Ecstasy pills obtained in the Netherlands to the United States. De Basseville and d’Esclavelles were arrested on June 1, 2006, in Arlington, Virginia, while meeting with undercover agents.

"The trail of dirty money is very hard to conceal,” said United States Attorney Rosenberg. “Here, two drug dealers and international money launderers are going to jail for a long time because federal agents and prosecutors relentlessly pursued their transactions."

This case was investigated by the Drug Enforcement Administration; the Federal Bureau of Investigation; the Internal Revenue Service; the Bureau of Alcohol, Tobacco, Firearms and Explosives; Immigration and Customs Enforcement; Customs Border Patrol; Arlington County Police Department; and Metropolitan (D.C.) Police Department. The United States Attorney’s Office also received considerable assistance from law enforcement authorities in the Netherlands and Switzerland. The case was prosecuted by Assistant United States Attorneys James Trump and Daniel Grooms.

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Christopher C. Goumenis Special Agent in Charge - Washington, DC
@DEAWashingtonDC
  • Facebook
  • X
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster